RGC

Regencell Bioscience Holdings (RGC)

About Regencell Bioscience Holdings (RGC)

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Details

Daily high

$20.02

Daily low

$18.10

Price at open

$19.00

52 Week High

$83.60

52 Week Low

$0.09

Market cap

9.8B

Dividend yield

0.00%

Volume

17,039

Avg. volume

245,315

P/E ratio

-2,751.39

Regencell Bioscience Holdings News